Methods: The study included 42 ears of 21 patients (11 males, 10 females; mean age 61 years; range 44 to 76 years) who underwent coronary artery bypass grafting. None of the patients had a history of cerebrovascular disease such as ischemic cerebrovascular event, syncope, or hearing loss. The number of arteries bypassed ranged from 1 to 4 (mean 2.7). The patients were examined with pure tone audiometry, speech discrimination test, and tympanometry, and transiently evoked (TEOAE) and distortion product (DPOAE) otoacoustic emissions were recorded preoperatively and on the postoperative sixth day. The pure tones were obtained at the frequencies of 250, 500, 1,000, 2,000, 4,000, and 6,000 Hz.
Results: None of the patients had hearing loss or sudden deafness after surgery. Preoperative and postoperative pure tone results of the patients did not differ significantly (p>0.05). The mean pre- and postoperative speech discrimination scores were 88±14% and 91±1%, respectively (p<0.05). Pre- and postoperative DPOAE findings did not differ significantly (p>0.05). Audiometric results showed no correlations with the number of bypassed arteries and operative variables (p>0.05).
Conclusion: Our findings suggest that coronary artery bypass grafting with extracorporeal circulation does not impose a risk for hearing loss and for the functions of outer hair cells in the inner ear.
Otoacoustic emissions (OAE) are acoustical signals, which occur spontaneously as narrow band tonal signals or after stimulation of the ear. This is an objective and noninvasive method to test functional status of the inner ear. Otoacoustic emissions can even show subtle changes in the inner ear functions before they become clinically evident. Both TEOAEs (transiently evoked OAE) and DPOAEs (distortion product OAE) are produced by active micromechanisms of the outer hair cells (OHCs) of the organ of Corti. The DPOAE, which is a consequence of normal nonlinear processes in the cochlea, has gained popularity as a clinical test for hearing screening, research and diagnostic purposes.[6-8]
This study was performed to examine the effects of CABG on hearing and inner ear status. This is the first study to assess the effects of CABG on OAE, as well.
Informed consent was obtained from all the patients. Pre- and postoperative audiologic assessments were performed by the same audiologist and otolaryngologist. While preoperative audiologic assessments included all the patients, postoperative assessment, which was performed on day 6, could be performed only in 21 patients. Five patients who were not available for postoperative assessment were excluded. Therefore, 42 ears of 21 patients (11 males, 10 females; mean age 61 years; range 44 to 76 years) were included in the analyses.
Audiologic evaluation
Pure tone audiometry and speech discrimination tests
were performed using an AC40 clinical audiometer
(Interacoustics, Assens, Denmark). Tympanometry and
TEOAE and DPOAE testing were performed. The pure
tones were obtained at the frequencies of 250, 500,
1,000, 2,000, 4,000, and 6,000 Hz.
The TEOAEs and DPOAEs were recorded consecutively and analyzed with the use of the ILO-96 cochlear emission analyzer (Otodynamics, London, United Kingdom). The TEOAEs were evoked by clicks of 80 ìsec duration, with a click rate of 50/sec. The stimulus level in the outer ear was 80±3 dB per sound pressure level. The post-stimulus time ranged from 2 to 20 msec. A total of 260 stimuli were averaged above the noise rejection level of 47 dB. Stimuli were presented nonlinearly, in that every three click stimuli were followed by an inverted stimulus that was three times greater in amplitude. The TEOAE response level was set as at least 3 dB of the level of the noise floor.
DPOAEs were measured using fixed intensity of the primary tones and data were recorded for frequency regions ranging from 1 to 6.3 kHz. Distortion product amplitudes were plotted as a function of f2 frequency. The ratio of the two primary tones (f2/f1) was 1.22. Stimulus levels were 65 dB and 55 dB for f1 and f2 frequencies, respectively. Distortion products obtained at 2f1-f2 exceeding the background noise by at least 3 dB were considered present.
Operation
Anesthesia was induced with 0.50 ìg/kg of remifentanil,
0.10 mg/kg of midazolam, 3.00 mg/kg of thiopental, and
0.90 mg/kg of rocuronium, and was maintained with
0.25-0.50 ìg/kg/hour of remifentanil and 3.00-6.00 mg/
kg/hour of propofol infusion. After standard sternotomy,
an ascending aortic cannula and two-stage venous cannula
were placed, extracorporeal oxygenation was maintained
by a membrane oxygenator (D 708 Simplex III,
Dideco, Mirandola, Italy). Ringer lactate (1500 ml) was
used as the prime solution. Anticoagulation was maintained
with heparin (3.0 mg/kg) and activated clotting
time was kept between 400 and 500 sec. Body temperature
was reduced to 28-32 ºC to achieve mild hypothermia.
At the early stage after the operation, respiration was
maintained with a volume-controlled respirator (T-Bird
VELA, Model: 1618602, Serial No: AET01172, Viasys
Healthcare, Conshohocken, PA, USA). The patients were
extubated after recovery from general anesthesia and
initiation of normal breathing. No ototoxic drug was
used during the perioperative period.
Statistical analysis
Preoperative and postoperative audiometric findings
were compared using the paired t-test. Comparisons
between different groups were made with the Kruskall-
Wallis test. Correlations were assessed with the
Spearman’s test.
Preoperative and postoperative pure tone results of the patients did not differ significantly (p>0.05; Table 1). Pre- and postoperative speech discrimination scores of the patients were 88±14% and 91±1%, respectively (p<0.05). None of the patients had hearing loss or sudden deafness after surgery.
Table 1: Frequency-specific pure tone audiometry results (mean dB±SD)
Pre- and postoperative DPOAE findings did not differ significantly (p>0.05; Table 2).
There are several mechanisms that may be associated with the occurrence of hearing loss after OHS. Shapiro et al.[11] reported that the presence of basilar artery atherosclerosis, prolonged pump time, and perfusion failure might be the most likely etiology of hearing loss. Walsted et al.[12] reported on four patients who developed profound sensorineural hearing loss following cardiac surgery with extracorporeal circulation, suggesting the possible role of microembolisms leading to the occlusion of the cochlear branch of the internal auditory artery. The type of the operation may also affect cerebral circulation. This is particularly true in some OHSs like valvular replacement and left ventricular aneurysm operations in which air embolism or emboli from atheromatous plaques may cause cerebrovascular events. In our series, the absence of postoperative hearing loss may be attributed to the absence of valvular replacement operations or patients with severe atherosclerosis.
Phillipps et al.[13] showed that patients undergoing CABG had statistically significant threshold shifts compared to controls, with four of 20 patients (5 ears) having developed statistically significant high-frequency hearing loss which was associated with age, minimum temperature and minimum blood pressure during the operation, and the duration of bypass. Low arterial blood pressure during or after CABG may affect cerebral hemodynamics and may result in hearing loss. None of the patients in our study had low cardiac output that could give rise to hearing impairment.
Despite the above-mentioned studies, a prospective study performed in 181 volunteers undergoing aortocoronary bypass surgery found no causal relationship between hearing loss and OHS and concluded that hearing loss occurring following OHS might be associated with ototoxic therapy.[14] On the other hand, hearing loss was also reported in three cases undergoing general surgery under general anesthesia without extracorporeal circulation and the authors proposed that microemboli or cochlear membrane breaks with perilymph fistulas due to increased middle ear pressure might be possible causes of sudden sensorineural hearing loss.[15] Bilateral hearing loss was also reported after a minor abdominal operation under general anesthesia.[16]
Hearing loss is less prevalent than neurological complications after cardiac surgery, suggesting the role of some factors other than extracorporeal circulation. It is of note that previous studies on hearing status after OHS were performed using conventional audiologic methods where subjective factors may not have been eliminated. However, OAE testing is objective and the use of OAE testing before and after OHS in larger series may provide more accurate information on the incidence and cause of hearing loss.
In our study, pure tone audiometry results and hearing thresholds of the patients did not change significantly after OHS. In addition, there was no significant change in the DPOAEs of the patients. The DPOAEs show outer hair cell status in the inner ear. In case of any detrimental effect on inner ear functions, a decrease is observed in their amplitudes even in the absence of a clinically evident threshold shift on pure tone audiometry. Thus, the absence of a DPOAE abnormality strongly suggests that CABG alone does not affect inner ear functions.
In conclusion, hearing loss, if any, occurring after CABG is probably due to the effects of general anesthesia rather than extracorporeal circulation and OHS. Our findings suggest that extracorporeal circulation does not impose a risk for hearing loss as well as for the functions of outer hair cells in the inner ear.
1) Plasse HM, Mittleman M, Frost JO. Unilateral sudden hearing
loss after open heart surgery: a detailed study of seven
cases. Laryngoscope 1981;91:101-9.
2) Plasse HM, Spencer FC, Mittleman M, Frost JO. Unilateral
sudden loss of hearing: an unusual complication of cardiac
operation. J Thorac Cardiovasc Surg 1980;79:822-6.
3) Arenberg IK, Allen GW, Deboer A. Sudden deafness immediately
following cardiopulmonary bypass. J Laryngol Otol
1972;86:73-7.
4) Young IM, Mehta GK, Lowry LD. Unilateral sudden hearing
loss with complete recovery following cardiopulmonary
bypass surgery. Yonsei Med J 1987;28:152-6.
5) Brownson RJ, Stroud MH, Carver WF. Extracorporeal cardiopulmonary
bypass and hearing. Arch Otolaryngol 1971;
93:179-82.
6) Liu TC, Hsu CJ, Hwang JH, Tseng FY, Chen YS. Effects of
alcohol and noise on temporary threshold shift in Guinea
pigs. ORL J Otorhinolaryngol Relat Spec 2004;66:124-9.
7) Shera CA. Mechanisms of mammalian otoacoustic emission
and their implications for the clinical utility of otoacoustic
emissions. Ear Hear 2004;25:86-97.
8) Korres S, Nikolopoulos T, Ferekidis E, Gotzamanoglou
Z, Georgiou A, Balatsouras DG. Otoacoustic emissions in
universal hearing screening: which day after birth should we
examine the newborns? ORL J Otorhinolaryngol Relat Spec
2003;65:199-201.
9) Slogoff S, Girgis KZ, Keats AS. Etiologic factors in neuropsychiatric
complications associated with cardiopulmonary
bypass. Anesth Analg 1982;61:903-11.
10) Mahanna EP, Blumenthal JA, White WD, Croughwell ND,
Clancy CP, Smith LR, et al. Defining neuropsychological
dysfunction after coronary artery bypass grafting. Ann Thorac
Surg 1996;61:1342-7.
11) Shapiro MJ, Purn JM, Raskin C. A study of the effects
of cardiopulmonary bypass surgery on auditory function.
Laryngoscope 1981;91:2046-52.
12) Walsted A, Andreassen UK, Berthelsen PG, Olesen A.
Hearing loss after cardiopulmonary bypass surgery. Eur Arch
Otorhinolaryngol 2000;257:124-7.
13) Phillipps JJ, Thornton AR. Audiometric changes in patients
undergoing coronary artery bypass surgery. Br J Audiol 1996;
30:19-25.
14) Ness JA, Stankiewicz JA, Kaniff T, Pifarre R, Allegretti J.
Sensorineural hearing loss associated with aortocoronary
bypass surgery: a prospective analysis. Laryngoscope 1993;
103:589-93.